Effects of Xanomeline and Trospium Chloride for Negative Symptoms Associated With Physical Activity in Younger and Older Adults with Schizophrenia: Results From a 52-Week, Open-label Clinical Trial

Schizophrenia Research 2026

View at publisher
Authors: Philip D. Harvey, Inder Kaul, Soumya Chataverdi, Tej Patel, Amy Claxton, Colin L. Sauder, Cameron D. Harvey, Stephen K. Brannan, William P. Horan
DOI: 10.1016/j.schres.2026.04.013
Cited by: 1
References: 42

Fields of Study & Subjects

Schizophrenia research and treatment Bipolar Disorder and Treatment Sleep and related disorders

Publication details

Journal / source
Schizophrenia Research
Publisher
Elsevier BV
Volume
294
Pages
44–51
Publication date
21 April 2026
Language
EN